Search

Deborah Strootman Phones & Addresses

  • Marana, AZ
  • 7670 Painted Ridge Pl, Tucson, AZ 85743
  • 8144 N Fallen Petal Dr, Tucson, AZ 85743
  • Arizona City, AZ

Work

Position: Medical Professional

Education

Degree: Associate degree or higher

Resumes

Resumes

Deborah Strootman Photo 1

Deborah Strootman

View page
Location:
7670 north Painted Ridge Pl, Tucson, AZ 85743
Industry:
Hospital & Health Care
Work:
University of Arizona Sarver Heart Center Jul 1, 2009 - Aug 1, 2015
Senior Research Nurse, Retired
Skills:
Critical Care
Clinical Research
Medicine
Emr
Medical Writing
Healthcare Management
Healthcare
Healthcare Information Technology
Patient Safety
Cardiology
Nursing
Hospitals
Interests:
Casinos
Exercise
Sweepstakes
Home Improvement
Reading
Gourmet Cooking
Sports
Golf
Food
Fishing
Home Decoration
Health
Cooking
Electronics
Outdoors
Crafts
Fitness
Music
Dogs
Family Values
Movies
Collecting
Christianity
Medicine
Automobiles
Travel
Career
Investing
Traveling
Languages:
English
Deborah Strootman Photo 2

Research Nurse, Rn, Bsn At University Of Arizona

View page
Position:
Research Nurse, RN, BSN at University of Arizona
Location:
Tucson, Arizona Area
Industry:
Higher Education
Work:
University of Arizona since Jul 2009
Research Nurse, RN, BSN

United Therapeutics Mar 2000 - Apr 2005
Clinical research scientist

Novartis Pharmaceuticals 1997 - 2000
Regional Scientific Director

Publications

Us Patents

Use Of Treprostinil To Treat Neuropathic Diabetic Foot Ulcers

View page
US Patent:
7879909, Feb 1, 2011
Filed:
Apr 12, 2005
Appl. No.:
11/103649
Inventors:
Michael Wade - Chapel Hill NC, US
Roger Andrew Jeffs - Chapel Hill NC, US
Deborah Strootman - Tucson AZ, US
Assignee:
United Therapeutics Corporation - Silver Spring MD
International Classification:
A61K 31/557
US Classification:
514573
Abstract:
The present invention describes novel methods for using 9-deoxy-2′,9-α-methano-3-oxa-4,5,6-trinor-3,7-(1′,3′-interphenylene)-13,14-dihydro-prostaglandin F(also known as Treprostinil) or its derivative, or a pharmaceutically acceptable salt thereof, for the treatment and/or prevention of foot ulcers in subjects with diabetic neuropathy. The invention also relates to kits for treatment and/or prevention of foot ulcers, comprising an effective amount of Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof.

Use Of Treprostinil To Treat Neuropathic Diabetic Foot Ulcers

View page
US Patent:
8563614, Oct 22, 2013
Filed:
Dec 20, 2010
Appl. No.:
12/926945
Inventors:
Michael Wade - Chapel Hill NC, US
Roger Andrew Jeffs - Chapel Hill NC, US
Deborah Strootman - Tucson AZ, US
Assignee:
United Therapeutics Corporation - Silver Spring MD
International Classification:
A61K 31/19
A61K 31/557
US Classification:
514573, 514569
Abstract:
The present invention describes novel methods for using 9-deoxy-2′,9-α-methano-3-oxa-4,5,6-trinor-3,7-(1′,3′-interphenylene)-13,14-dihydro-prostaglandin F(also known as Treprostinil) or its derivative, or a pharmaceutically acceptable salt thereof, for the treatment and/or prevention of foot ulcers in subjects with diabetic neuropathy. The invention also relates to kits for treatment and/or prevention of foot ulcers, comprising an effective amount of Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof.

Use Of Treprostinil To Improve Kidney Functions

View page
US Patent:
20050165110, Jul 28, 2005
Filed:
Dec 16, 2004
Appl. No.:
11/012722
Inventors:
Michael Wade - Chapel Hill NC, US
Roger Andrew Jeffs - Chapel Hill NC, US
Kathryn Bronstein - Jupiter FL, US
Deborah Strootman - Tucson AZ, US
International Classification:
A61K031/557
US Classification:
514573000
Abstract:
The present invention describes novel methods for using Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof, for improving kidney functions, such as urine output, and treating symptoms associated with kidney malfunction or failure. The invention also relates to kits for the improvement of kidney functions and the treatment of symptoms associated with kidney malfunction or failure, comprising an effective amount of Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof.

Use Of Treprostinil To Treat And Prevent Ischemic Lesions

View page
US Patent:
20050165111, Jul 28, 2005
Filed:
Dec 16, 2004
Appl. No.:
11/012723
Inventors:
Michael Wade - Chapel Hill NC, US
Roger Jeffs - Chapel Hill NC, US
Robert Roscigno - Chapel Hill NC, US
Deborah Strootman - Tucson AZ, US
Kathryn Bronstein - Jupiter FL, US
International Classification:
A61K031/557
US Classification:
514573000
Abstract:
The present invention describes novel methods for using Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof, for the treatment and/or prevention of ischemic lesions, such as digital ulcers, in subjects with scleroderma (including systemic sclerosis), Buerger's disease, Raynaud's disease, Raynaud's phenomenon and/or other conditions that cause such lesions. The invention also relates to kits for treatment and/or prevention of ischemic lesions, comprising an effective amount of Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof.
Deborah H Strootman from Marana, AZ, age ~72 Get Report